Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Positron Corp. (OTC: POSC).

Full DD Report for POSC

You must become a subscriber to view this report.

Recent News from (OTC: POSC)

Positron Announces Sale Of Attrius PET Scanner
NIAGARA FALLS, N.Y. , Oct. 2, 2018 /PRNewswire/ -- Positron Corporation (OTC:POSC)(the "Company"), a nuclear medicine healthcare company, is pleased to announce the sale of its Attrius PET scanner to a prominent cardiology practice in the US as they expand their services to includ...
Source: PR Newswire
Date: October, 02 2018 11:00
Positron Appoints New Management
NIAGARA FALLS, N.Y. , Sept. 27, 2018 /PRNewswire/ -- Positron Corporation (OTC:POSC)(the "Company"), a nuclear medicine healthcare company, announces the appointment of Adel Abdullah  as its President. Mr. Abdullah will also serve as a Director of the Board. Mr. Abdullah will ...
Source: PR Newswire
Date: September, 27 2018 11:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on POSC.

About Positron Corp. (OTC: POSC)

Logo for Positron Corp. (OTC: POSC)

Positron is a nuclear medicine healthcare company specializing in the business of cardiac Positron Emission Tomography PET . Cardiac PET is the superior method in diagnostic nuclear imaging for the detection of coronary artery disease CAD , a leading cause of death in the United States. Positron s products and services empower healthcare providers to more accurately diagnose CAD and improve patient outcomes while practicing cost effective medicine. Positron, a pioneer in nuclear cardiology for over years, is establishing a unique position by vertically integrating the fragmented and limited supply environment that exists in the cardiac PET marketplace today. Positron s approach is to provide nuclear cardiologists an end to end solution by offering award winning imaging technology, clinical services, imaging agents and innovative financing packages conveniently from a single source. Positron s approach in securing the cardiac PET supply chain will bring substantial advantages in accelerating the adoption of this superior modality and growth of the nuclear cardiology industry.


Contact Information



Current Management

  • Joseph Oliverio / President
  • Corey Conn / CFO

Current Share Structure

  • Market Cap: $450,122 - 03/16/2018
  • Authorized: 6,000,000,000 - 03/12/2018
  • Issue and Outstanding: 10,978,574 - 03/12/2018


Daily Technical Chart for (OTC: POSC)

Daily Technical Chart for (OTC: POSC)

Stay tuned for daily updates and more on (OTC: POSC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: POSC)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in POSC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of POSC and does not buy, sell, or trade any shares of POSC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: